Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04428905 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer

StatusActive, Not Recruiting
PhasePhase 3
Started2020-07-11
View on ClinicalTrials.gov ↗

Amendment history

2026-02-23
Study Status v13
Primary completion date2026-09-30→2027-03-31
Completion date2026-09-30→2027-03-31
2025-07-03
Study Status, Study Design, Document Section v12
PhaseNot applicable→Phase 3
Primary completion date2025-06-01→2026-09-30
Completion date2026-03-31→2026-09-30
2024-10-11
Study Status v11
Primary completion date2024-10-30→2025-06-01
Completion date2025-03-31→2026-03-31
2024-08-01
Recruiting→Active, Not Recruiting Study Status, Study Design, Contacts/Locations v10
Trial statusRecruiting→Active, Not Recruiting
Primary completion date2024-06-30→2024-10-30
Enrollment targetestimated 414→confirmed 403
Study sitesdetails revised at 1 of 1 site
2024-03-20
Study Status v9
Re-verified, no change to tracked fields
Show 8 earlier versions
2024-03-15
Study Status, Study Description v8
Study description+103 characters
PRIMARY OBJECTIVES: TheI. primary purpose of this proposal is to determineDetermine the efficacy of a telehealth survivorship self-management (SSM)the intervention on care coordination, communication, and primary care provider (PCP) knowledge, comparing the intervention and attention control arms at 4 and 8 months post-accrual. II. Determine the efficacy of the intervention on survivor outcomes, incomparing 414the adults with a history of lungintervention and colorectalattention cancercontrol arms at 4 and 8 months post-accrual. EXPLORATORY OBJECTIVE: I. Assess the reach, efficacy, adop [...]
2024-03-13
Study Status, Study Description v7
Study description-103 characters
PRIMARY OBJECTIVES: I.The Determineprimary purpose of this proposal is to determine the efficacy of thea telehealth survivorship self-management (SSM) intervention on care coordination, communication, and primary care provider (PCP) knowledge, comparing the intervention and attention control arms at 4 and 8 months post-accrual. II. Determine the efficacy of the intervention on survivor outcomes, comparingin the414 interventionadults with a history of lung and attentioncolorectal control arms at 4 and 8 months post-accrualcancer. EXPLORATORY OBJECTIVE: I. Assess the reach, efficacy, adop [...]
2023-04-06
Study Status v6
Re-verified, no change to tracked fields
2022-04-05
Study Status v5
Primary completion date2025-03-23→2024-06-30
Completion date2025-03-23→2025-03-31
2022-02-17
Study Status v4
Primary completion date2024-06-30→2025-03-23
Completion date2025-03-31→2025-03-23
2021-02-15
Study Status v3
Primary completion date2024-01-23→2024-06-30
Completion date2024-01-23→2025-03-31
Start date2020-03-23→2020-07-11
2020-07-23
2 amendments v1-v2
2 re-verifications since 2020-06-11, no change to tracked fields
2020-06-09
Original filing
This phase III trial studies how well a telehealth self-management program works in improving survivorship care and outcomes in stage I-III non-small cell lung cancer or colorectal cancer survivors. Survivor self-management program focuses on coaching patients on follow-up care after cancer treatments. Participating in the program may improve knowledge and confidence about follow-up care, communication with cancer care and primary care doctors, and quality of life after cancer treatment in non-small cell lung cancer or colorectal cancer survivors.
Trial Details
NCT Number NCT04428905
Lead Sponsor City of Hope Medical Center
Collaborators: National Cancer Institute (NCI)
Conditions Lung Non-Small Cell Carcinoma, Stage I Colorectal Cancer AJCC v8, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8, Stage IA2 Lung Cancer AJCC v8, Stage IA3 Lung Cancer AJCC v8, Stage IB Lung Cancer AJCC v8, Stage II Colorectal Cancer AJCC v8 +14 more
Enrollment 403 participants
Start Date 2020-07-11
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-24